Inhibitory effects of cocoa tea (Camellia ptilophylla) in human hepatocellular carcinoma HepG2 in vitro and in vivo through apoptosis

Journal of Nutritional Biochemistry

Volumn 23, Issue 9, 2012, Pages 1051-1057

  Yang, Xiao rong ^a   Wang, Yuan yuan ^a   La, Kai Kai ^a   Peng, Li ^a   Song, Xiao hong ^a   Shi, Xiang gang ^a   Zhu, Xiao feng ^b   Leung, Ping chung ^c   Ko, Chun hay ^c   Ye, Chuang xing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Camellia ptilophylla; Cocoa tea; GCG; HepG2; Theobromine

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; FLUOROURACIL; GREEN COCOA TEA INFUSION; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CACAO; CAMELLIA PTILOPHYLLA; CELL CYCLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEA; TUMOR GROWTH; TUMOR VOLUME;

CAMELLIA; MUS MUSCULUS; THEOBROMA CACAO;

EID: 84865095121     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.05.010     Document Type: Article

References (39)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics 2009. CA Cancer J Clin 2009, 59:225-249.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
3. Nerenstone S.R., Ihde D.C., Friedman M.A. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 1988, 15(1):1-31.
4. Leung T.W., Patt Y.Z., Lau W.Y., et al. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 1999, 5(7):1676-1681.
5. Thomas M.B., O'Beirne J.P., Furuse J., Chan A.T., Abou-Alfa G., Johnson P. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol 2008, 15(4):1008-1014.
6. Lee J.S., Chu I.S., Heo J., Calvisi D.F., Sun Z., Roskams T., et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004, 40(3):667-676.
7. Demeule M., Michaud-Levesque J., Annabi B., et al. Green tea catechins as novel antitumor and antiangiogenic compounds. Curr Med Chem Anticancer Agents 2002, 2:441-463.
8. Ju J., Hong J., Zhou J.N., Pan Z., Bose M., Liao J., Yang G.Y., Liu Y.Y., Hou Z., et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 2005, 65:10623-10631.
9. Yang C.S., Maliakal P., Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002, 42:25-54.
10. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997, 89:1881-1886.
11. Siddiqui I.A., Adhami V.M., Afaq F., Ahmad N., Mukhtar H. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem 2004, 91(2):232-242.
12. Sukhthankar M., Yamaguchi K., Lee S.H., McEntee M.F., Eling T.E., Hara Y., et al. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology 2008, 134(7):1972-1980.
13. Heckman M.A., Weil J., Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010, 75(3):R77-87.
14. Huang K.J., Wu J.J., Chiu Y.H., Lai C.Y., Chang C.M. Designed polar cosolvent-modified supercritical CO2 removing caffeine from and retaining catechins in green tea powder using response surface methodology. J Agric Food Chem 2007, 55(22):9014-9020.
15. Ito E., Crozier A., Ashihara H. Theophylline metabolism in higher plants. Biochim Biophys Acta 1997, 1336(2):323-330.
16. He R.R., Xie G., Yao X.S., Kurihara H. Effect of cocoa tea (Camellia ptilophylla) co-administrated with green tea on ambulatory behaviors. Biosci Biotechnol Biochem 2009, 73(4):957-960.
17. Kurihara H., Shibata H., Fukui Y., Kiso Y., Xu J.K., Yao X.S., et al. Evaluation of the hypolipemic property of Camellia sinensis var. ptilophylla on postprandial hypertriglyceridemia. J Agric Food Chem 2006, 54(14):4977-4981.
18. Peng L., Khan N., Afaq F., Ye C., Mukhtar H. In vitro and in vivo effects of water extract of white cocoa tea (Camellia ptilophylla) against human prostate cancer. Pharm Res 2010, 27:1128-1137.
19. Peng L., Song X.H., Shi X.G., Li J.X., Ye C.X. An improved HPLC method for simultaneous determination of phenolic compounds, purine alkaloids and theanine in Camellia species. J Food Compos Anal 2008, 21:559-563.
20. Tan M.L., Ooi J.P., Ismail N., Moad A.I., Muhammad T.S. Programmed cell death pathways and current antitumor targets. Pharm Res 2009, 26(7):1547-1560.
21. Goh A.M., Coffill C.R., Lane D.P. The role of mutant p53 in human cancer. J Pathol 2011, 223(2):116-126.
22. Yu Y., Kovacevic Z., Richardson D.R. Tuning cell cycle regulation with an iron key. Cell Cycle 2007, 6(16):1982-1994.
23. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999, 6:1028-1042.
24. Grutter M.G. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000, 10:649-655.
25. Nunez G., Benedict M.A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene 1998, 17:3237-3245.
26. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999, 342(Pt 2):249-268.
27. Chung Y.L., Sheu M.L., Yen S.H. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer 2003, 107:65-73.
28. De Miglio M.R., Muroni M.R., Simile M.M., Calvisi D.F., Tolu P., Deiana L., et al. Implication of Bcl-2 family genes in basal and d-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesions. Hepatology 2000, 31:956-965.
29. Lee M.H., Han D.W., Hyon S.H., Park J.C. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB. Apoptosis 2011, 16(1):75-85.
30. Kuo P.L., Lin C.C. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci 2003, 10(2):219-227.
31. Shirakami Y., Shimizu M., Adachi S., Sakai H., Nakagawa T., Yasuda Y., et al. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci 2009, 100(10):1957-1962.
32. Kinjo J., Nagao T., Tanaka T., Nonaka G., Okawa M., Nohara T., et al. Activity-guided fractionation of green tea extract with antiproliferative activity against human stomach cancer cells. Biol Pharm Bull 2002, 25(9):1238-1240.
33. Xu J.Z., Yeung S.Y., Chang Q., Huang Y., Chen Z.Y. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr 2004, 91(6):873-881.
34. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., Fujiki H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 1999, 59(1):44-47.
35. Horie N., Hirabayashi N., Takahashi Y., Miyauchi Y., Taguchi H., Takeishi K. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells. Biol Pharm Bull 2005, 28(4):574-579.
36. Williams S.N., Pickwell G.V., Quattrochi L.C. A combination of tea (Camellia senensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract. J Agric Food Chem 2003, 51(22):6627-6634.
37. Smit H.J. Theobromine and the pharmacology of cocoa. Handb Exp Pharmacol 2011, 200:201-234.
38. Kuribara H., Tadokoro S. Behavioral effects of cocoa and its main active compound theobromine: evaluation by ambulatory activity and discrete avoidance in mice. Arukoru Kenkyuto Yakubutsu Ison 1992, 27(2):168-179.
39. Shi D., Daly J.W. Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol 1999, 19(6):719-732.